bioRxivBiochemistry
POMK Regulates Dystroglycan Function via LARGE-mediated Elongation of Matriglycan
A. S. Walimbe, H. Okuma, S. Joseph, T. Yang, T. Yonekawa, J. M. Hord, D. Venzke, M. E. Anderson, S. Torelli, A. Manzur, M. Devereaux, M. Cuellar, S. Prouty, S. Ocampo Landa, L. Yu, J. Xiao, J. E. Dixon, F. Muntoni, K. P. Campbell
Abstract
Matriglycan [-GlcA-{beta}1,3-Xyl-1,3-]n serves as a scaffold in many tissues for extracellular matrix proteins containing laminin-G domains including laminin, agrin, and perlecan. Like-acetylglucosaminyltransferase-1 (LARGE) synthesizes and extends matriglycan on -dystroglycan (-DG) during skeletal muscle differentiation and regeneration; however, the mechanisms which regulate matriglycan elongation are unknown. Here, we show that Protein O-Mannose Kinase (POMK), which phosphorylates mannose of core M3 (GalNac-{beta}1,3-GlcNac-{beta}1,4-Man) preceding matriglycan synthesis, is required for LARGE-mediated generation of full-length matriglycan on -DG ([~]150 kDa). In the absence of POMK, LARGE synthesizes a very short matriglycan resulting in a [~]90 kDa -DG in mouse skeletal muscle which binds laminin but cannot prevent eccentric contraction-induced force loss or muscle pathology. Solution NMR spectroscopy studies demonstrate that LARGE directly interacts with core M3 and binds preferentially to the phosphorylated form. Collectively, our study demonstrates that phosphorylation of core M3 by POMK enables LARGE to elongate matriglycan on -DG, thereby preventing muscular dystrophy.
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: development & morphogenesis
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dystroglycan N-terminal domain enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy
H. Okuma, J. M. Hord, … K. P. Campbell·eLifePeer-reviewed·Feb 1, 2023
- Identification of a short, single site matriglycan that maintains neuromuscular function in the mouse
T. Yang, I. Chandel, … K. P. Campbell·bioRxiv·Dec 20, 2023
- Structure and mechanism of LARGE1 matriglycan polymerase
S. Joseph, N. J. Schnicker, … K. P. Campbell·bioRxiv·May 12, 2022
- Xylose phosphatase activity of dystroglycan self-regulates its receptor function
Ishita Chandel, David P. Venzke, … Kevin P. Campbell·SciencePeer-reviewed·Aug 13, 2026
- Removal of pomt1 in zebrafish leads to loss of α-dystroglycan glycosylation and dystroglycanopathy phenotypes
Brittany F. Karas, Kristin R. Terez, … M. Chiara Manzini·Human Molecular GeneticsPeer-reviewed·Jan 25, 2024
- The homodimeric structure of the LARGE1 dual glycosyltransferase
Michael Katz, Ron Diskin·bioRxiv·May 11, 2022